Schedule of Significant Expense Categories |
The following table is representative of the significant expense
categories regularly provided to the CODM when managing the Company’s single reporting segment. A reconciliation to the consolidated
net income (loss) for the three months ended March 31, 2025 and 2024 is included at the bottom of the table below.
Schedule of Significant Expense Categories
| |
2,025 | | |
2,024 | |
| |
Three Months Ended March 31, | |
| |
2025 | | |
2024 | |
Total revenues | |
$ | 93,864 | | |
$ | 7,617,174 | |
Program expenses (1) | |
| | | |
| | |
LPCN 1154 | (1) |
| 6,692 | | |
| 1,652,486 | |
Other research and development programs | (1) |
| 290,546 | | |
| 402,410 | |
Non-program expenses (2) | |
| 731,043 | | |
| 1,203,846 | |
Personnel costs | |
| 1,084,765 | | |
| 1,036,597 | |
Stock-based compensation | |
| 71,002 | | |
| 99,306 | |
Total segment operating income (loss) | |
| (2,090,184 | ) | |
| 3,222,529 | |
Other income (loss) (3) | |
| 225,311 | | |
| 291,092 | |
Net income (loss) | |
$ | (1,864,873 | ) | |
$ | 3,513,621 | |
|
(1) |
Includes external research and development expenses. |
|
|
|
|
(2) |
Includes general and administrative expenses, information technology,
infrastructure, facilities, and intellectual property, and legal and professional fees. |
|
|
|
|
(3) |
Includes interest income and loss on warrant liability. |
|